Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BGM GALECTIN -3

K-Number: K093758 · 2010-11-17

Decision Date2010-11-17
Product CodeOSX
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

BGM GALECTIN -3 is the device name listed in this FDA 510(k) record. The listed applicant is Bg Medicine, Inc.. It received FDA 510(k) clearance on 2010-11-17 under 510(k) number K093758. The device is classified under product code OSX. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BGM GALECTIN -3?

BGM GALECTIN -3 is a medical device that received FDA 510(k) clearance on 2010-11-17. The listed applicant is Bg Medicine, Inc.. The 510(k) number is K093758.

When did BGM GALECTIN -3 receive FDA 510(k) clearance?

BGM GALECTIN -3 received FDA 510(k) clearance on 2010-11-17, under 510(k) number K093758.

Who is the listed applicant for BGM GALECTIN -3?

The FDA 510(k) record lists Bg Medicine, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BGM GALECTIN -3?

The FDA product code for BGM GALECTIN -3 is OSX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑